Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
Crossref DOI link: https://doi.org/10.1007/s10120-017-0710-0
Published Online: 2017-03-16
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cho, Hyungwoo
Ryu, Min-Hee
Kim, Kyu-pyo
Ryoo, Baek-Yeol
Park, Sook Ryun
Kim, Bum Soo
Lee, In-Seob
Kim, Hee-Sung
Yoo, Moon-Won
Yook, Jeong Hwan
Oh, Seong Tae
Kim, Byung Sik
Kang, Yoon-Koo
License valid from 2017-03-16